Spinner,

I agree and disagree to an extent. Usually what I have seen in Biotech when finances are an issue, is that they will continually dilute and then do a reverse further down the road. That is not the case with GNBT as someone has posted over the last week. I do still remain guardedly optimistic about the future and as I indicated previously, if this continues to go down, I will buy more shares and average down a little bit more. I have always been a gambler, and I am willing to pull the handle of this slot machine of a company. Like they say, don't invest money that you cannot afford to loose.